No Data
On January 2, KINGDEE INT'L (00268.HK) spent 1.3494 million HKD to repurchase 0.167 million shares.
Gelonghui, January 2 | KINGDEE INT'L (00268.HK) announced that on January 2, 2024, it spent 1.3494 million Hong Kong dollars to repurchase 0.167 million shares, with a repurchase price of 8.08 Hong Kong dollars per share.
In 2024, Hong Kong stocks: The Hang Seng Index reached a new high in nearly four years, and the net Inflow of southbound funds exceeded 700 billion.
① How does the overall trend of the Hong Kong stock market perform in 2024? ② What role does southbound capital play in the Hong Kong stock market in 2024? ③ What is the perspective of Institutions for 2025?
Is Kingdee International Software Group (HKG:268) Using Too Much Debt?
Bank of America Securities: Recommend "Buy" for KINGSOFT (03888) and KINGDEE INT'L (00268), with both Target Prices adjusted upwards.
Bank of America Securities raised Kingsoft's target price from 38 HKD to 45 HKD and raised Kingdee's target price from 11.1 HKD to 13.2 HKD.
Nomura: Next year, the China National Software & Service industry will need stimulus measures. It is recommended to buy Kingsoft and Kingdee Int'l.
Nomura released a research report stating that stimulus policies, localization, and ai investment will support the recovery of the china national software & service industry starting in the second quarter of next year. The firm believes that due to the strong sentiment for government fiscal stimulus, the china software index has risen 76% in the past 60 days, recovering ground lost in 2024. It is also believed that the economic stimulus plan will need some time to take effect before technology spending rebounds. It is recommended to buy kingsoft (03888) and kingdee int'l (00268). The report mentions that considering the weak seasonal nature of the first quarter of next year, if significant signs of macroeconomic recovery appear, Nomura believes that the china software.
Hong Kong stock afternoon review | Hang Seng Index rose 1.40% in the morning, CRO concept stocks performed well in the morning.
The probability of the Federal Reserve lowering interest rates this month remains quite high, and both domestic and foreign pharmaceutical investments and financing are expected to gradually recover.
